Hereditary angioedema or HAE in short, is a rare genetic disorder in which patients experience sudden onset of swelling in various locations of the body. There are two kinds of HAE treatments - preventive and on-demand. While preventive or prophylactic HAE treatment helps prevent or minimize the frequency and severity of HAE attacks, the on-demand HAE treatment is used to treat the symptoms of a HAE attack.
The company we are profiling today is KalVista Pharmaceuticals Inc. (KALV), which is developing a franchise of oral treatments for HAE - both on-demand and prophylactic HAE drugs.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.